2nd Rare CNS and Neurodevelopmental Drug Development Summit
Evvnt Promotion / evvnt
Archivo
28.11.2022 - 30.11.2022 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:00 am - 3:50 pm
Temas de la conferencia
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.
The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.
The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832
Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832
Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.
Información e inscripción:
https://go.evvnt.com/1289306-2?pid=4832
Ms. Emily Lincoln
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
